+ 7 (495) 684-04-00

Ideas

Our observations, insights and news from the investment world

Biotech – Analysis and Outlook

AVC have focused on the two leading Biotech ETFs over the last few years, but it has been a tough year. We follow XBI and IBB. XBI is SPDR S&P Biotech, and IBB is iShares Biotechnology.

January Market Expectations

Mid-Term Januarys usually provide less than optimal market conditions for investors. They also are less prescriptive of the rest of the year's returns.
To access this post, you must purchase Subscription Plan – AVC Pro.

Friday Investment Talk: Christmas Gifts, ETF Inflows, Housing, and US Population

Ray Dalio suggests gifting gold coins for Christmas, while investors set records for ETF inflows in 2021. ESG ETFs grew while IPO ETFs underperform. Markets sold off in December providing a bullish setup in two pet supply companies as put/call ratios roll over to buy signals for the S&P 500 index. Beware of mid-term US …

Friday Investment Talk: Christmas Gifts, ETF Inflows, Housing, and US Population Read More »

Flattened Alibaba

Analysts have a neutral view of Alibaba (BABA) going into 2022. They see revenue across all business lines slowing from pandemic levels. But growth rates are still strong, and new business lines are just in their infancy. The negativity among analysts is palatable. Longer term, they maybe overdone.

Now A Nibble

With 'stay at home' COVID pet purchases fueling a frenzy in animal health products, this pet care delivery service boomed. On the 'return to normal' trade, the company has fallen out of favor, undeservedly so as growth is still robust and margins expand.
To access this post, you must purchase Subscription Plan – AVC Pro.

More Beat Up Blue Chips

Recently we highlighted several best-of-breed large capitalization companies that have materially under performed this year. Another three companies are examined below. These are not speculative names. They are not richly valued technology or consumer discretionary stocks either. They have wide defensive moats and should be beneficiary of strong cyclical and secular uptrend. But they under performed enough during 2021 with …

More Beat Up Blue Chips Read More »

To access this post, you must purchase Subscription Plan – AVC Pro.

Friday Investment Talk: Oil and Energy, Real Estate, Sector Rotation

Energy markets look to be in a long term bull market with continued strength in oil prices fueling additional exploration. Real Estate prices for residential housing are rising faster than rents. Likely rents will play catch up in 2022. Sector rotation towards quality and low volatility is taking place since the Federal Reserve has began …

Friday Investment Talk: Oil and Energy, Real Estate, Sector Rotation Read More »

Beaten Down Blue Chips

Several high quality companies now sell for discounted prices after the strong sell since Thanksgiving. The main US indexes maintain relatively high sales and earnings multiples historically. This masks the damage done to most small stocks and even some blue chip names that most astute investors continually monitor for buying opportunities. We highlight three stocks …

Beaten Down Blue Chips Read More »

To access this post, you must purchase Subscription Plan – AVC Pro.

2021 US Markets Review

US markets were top performers in 2021. Fed tapering became the year's theme as inflation began showing up in the Spring. Bonds sold off, and yields rose. Chinese companies suffered as a crackdown on foreign listed stocks erupted in Q3. The US maintains its top ranking of all equity markets going into 2022.

Friday Investment Talk: Macroeconomics, Financial Repression in 2022

High debt levels and inflation create difficulties for investors in 2022. ‘Financial Repression’ could become a household phrase. Inflationary pressures will put certain sectors in the spotlight. We watch oil and gas exploration and production, consumer staples and real estate as places for outperformance. A quick look the Russian ETF (RSX) reveals its need to …

Friday Investment Talk: Macroeconomics, Financial Repression in 2022 Read More »

For Whom

Our Expertise

Our Solutions

This information is not an individual investment recommendation, and the financial instruments or transactions mentioned in it may not correspond to your investment profile and investment goals (expectations). It is your task to determine whether a financial instrument or transaction matches your interests, investment objectives, investment horizon and acceptable risk level. AVC Adisvory, Inc. and its affiliates are not liable for possible losses in case of making transactions or investing in the financial instruments mentioned in this information, and do not recommend using this information as the only source of information when making an investment decision.

Twitter Facebook Linkedin-in Youtube Telegram-plane
Scroll to Top